Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
41.59
-0.25 (-0.60%)
At close: Apr 26, 2024, 4:00 PM
40.34
-1.25 (-3.01%)
After-hours: Apr 26, 2024, 7:57 PM EDT
Ionis Pharmaceuticals Revenue
In the year 2023, Ionis Pharmaceuticals had annual revenue of $787.65M with 34.10% growth. Revenue in the quarter ending December 31, 2023 was $324.51M with 113.65% year-over-year growth.
Revenue (ttm)
$787.65M
Revenue Growth
+34.10%
P/S Ratio
7.70
Revenue / Employee
$849,673
Employees
927
Market Cap
6.06B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 787.65M | 200.28M | 34.10% |
Dec 31, 2022 | 587.37M | -223.09M | -27.53% |
Dec 31, 2021 | 810.46M | 81.19M | 11.13% |
Dec 31, 2020 | 729.26M | -393.34M | -35.04% |
Dec 31, 2019 | 1.12B | 522.93M | 87.20% |
Dec 31, 2018 | 599.67M | 85.50M | 16.63% |
Dec 31, 2017 | 514.18M | 141.40M | 37.93% |
Dec 31, 2016 | 372.78M | 89.07M | 31.40% |
Dec 31, 2015 | 283.70M | 69.54M | 32.47% |
Dec 31, 2014 | 214.16M | 66.88M | 45.41% |
Dec 31, 2013 | 147.29M | 45.24M | 44.33% |
Dec 31, 2012 | 102.05M | 2.96M | 2.99% |
Dec 31, 2011 | 99.09M | -9.39M | -8.65% |
Dec 31, 2010 | 108.47M | -13.13M | -10.80% |
Dec 31, 2009 | 121.60M | 14.41M | 13.44% |
Dec 31, 2008 | 107.19M | 48.85M | 83.72% |
Dec 31, 2007 | 58.34M | 43.49M | 292.65% |
Dec 31, 2006 | 14.86M | -25.27M | -62.98% |
Dec 31, 2005 | 40.13M | -2.49M | -5.84% |
Dec 31, 2004 | 42.62M | -7.37M | -14.73% |
Dec 31, 2003 | 49.99M | -30.19M | -37.65% |
Dec 31, 2002 | 80.18M | 26.91M | 50.51% |
Dec 31, 2001 | 53.27M | 16.02M | 43.00% |
Dec 31, 2000 | 37.26M | 3.33M | 9.82% |
Dec 31, 1999 | 33.93M | -5.25M | -13.39% |
Dec 31, 1998 | 39.17M | 6.45M | 19.71% |
Dec 31, 1997 | 32.72M | 10.06M | 44.39% |
Dec 31, 1996 | 22.66M | 6.70M | 41.94% |
Dec 31, 1995 | 15.97M | 454.00K | 2.93% |
Dec 31, 1994 | 15.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.32B |
Elanco Animal Health | 4.42B |
Bausch + Lomb | 4.15B |
DENTSPLY SIRONA | 3.97B |
The Ensign Group | 3.73B |
Acadia Healthcare Company | 2.93B |
Apellis Pharmaceuticals | 396.59M |
Blueprint Medicines | 249.38M |
IONS News
- 2 days ago - Ionis Publishes 2023 Corporate Responsibility Report - PRNewsWire
- 4 days ago - Ionis to hold first quarter 2024 financial results webcast - PRNewsWire
- 20 days ago - Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome - PRNewsWire
- 26 days ago - Ionis to present at upcoming investor conferences - PRNewsWire
- 4 weeks ago - Ionis to hold olezarsen Phase 3 data webcast - PRNewsWire
- 4 weeks ago - Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting - PRNewsWire
- 6 weeks ago - Ionis Pharma's fatty liver disease drug succeeds in mid-stage trial - Reuters
- 6 weeks ago - Ionis announces positive results from Phase 2 study of ION224, an investigational medicine demonstrating clinical efficacy in the treatment of NASH/MASH - PRNewsWire